Lisa Kueltzo

Title: Innovations by Lisa Kueltzo in HIV-1 Research

Introduction

Lisa Kueltzo is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of HIV research, particularly through her innovative work on neutralizing antibodies. With a total of 2 patents, her inventions focus on methods to detect and treat HIV-1 infections.

Latest Patents

Lisa's latest patents include "10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use." This patent discloses neutralizing antibodies that specifically bind to HIV-1 Env and antigen binding fragments of these antibodies. It also provides nucleic acids encoding these antibodies, vectors, and host cells. Furthermore, methods for detecting HIV-1 using these antibodies are disclosed. The patent emphasizes the use of these antibodies, antigen binding fragments, nucleic acids, and vectors to prevent and/or treat an HIV-1 infection. Another significant patent is "Neutralizing antibodies to HIV-1 GP41 and their use," which shares similar findings and applications.

Career Highlights

Throughout her career, Lisa has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Columbia University. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Lisa has collaborated with notable colleagues, including Young Do Kwon and Ivelin Georgiev. These partnerships have further enriched her research and innovation in the field of HIV.

Conclusion

Lisa Kueltzo's work in developing neutralizing antibodies for HIV-1 represents a significant advancement in medical research. Her contributions are vital in the ongoing fight against HIV, showcasing the importance of innovation in healthcare.